160 related articles for article (PubMed ID: 11221022)
1. Current status of irinotecan in lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan: summary and future directions.
Johnson DH
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):46-7. PubMed ID: 11221021
[No Abstract] [Full Text] [Related]
3. Irinotecan in small-cell lung cancer: the US experience.
Sandler AB
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015
[TBL] [Abstract][Full Text] [Related]
4. [Irinotecan].
Yokoyama A
Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
[No Abstract] [Full Text] [Related]
5. Irinotecan therapy for small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer.
Wu HG; Choy H
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):13-8. PubMed ID: 12375796
[TBL] [Abstract][Full Text] [Related]
7. Role of topoisomerase I inhibitors in small-cell lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.
Choy H; MacRae R
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):31-6. PubMed ID: 11221019
[TBL] [Abstract][Full Text] [Related]
9. Current role of irinotecan in the treatment of non-small-cell lung cancer.
Kelly K
Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan in the treatment of small cell lung cancer.
Masuda N; Fukuoka M
Expert Rev Anticancer Ther; 2001 Aug; 1(2):187-95. PubMed ID: 12113024
[TBL] [Abstract][Full Text] [Related]
11. [Taxol in bronchial carcinoma].
Gatzemeier U
Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
[No Abstract] [Full Text] [Related]
12. [Role of irinotecan in the treatment of small cell carcinoma].
Crinò L
Tumori; 2001; 87(6):A35-7. PubMed ID: 11995707
[No Abstract] [Full Text] [Related]
13. Irinotecan in small-cell lung cancer--Japanese trials.
Fukuoka M; Masuda N; Kudoh S; Negoro S
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan and radiation in combined-modality therapy for solid tumors.
Choy H; MacRae R
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
[TBL] [Abstract][Full Text] [Related]
15. New state of the art in small-cell lung cancer.
Tamura T
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):8-10. PubMed ID: 11221023
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical trials of topoisomerase inhibitors.
Saijo N
Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.
Adjei AA; Argiris A; Murren JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin and its analogs. An overview of their potential in cancer therapeutics.
Muggia FM; Dimery I; Arbuck SG
Ann N Y Acad Sci; 1996 Dec; 803():213-23. PubMed ID: 8993515
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies of CPT-11 in Japan.
Taguchi T
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():277-83. PubMed ID: 7661595
[No Abstract] [Full Text] [Related]
20. Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
Devore R; Johnson D; Crawford J; Dimery I; Eckardt J; Eckhardt SG
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):79-83. PubMed ID: 9726097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
